A comprehensive review of mutations in the MERTK proto-oncogene

Advances in Experimental Medicine and Biology

Volumn 854, Issue , 2016, Pages 259-265

  Parinot, Célia ^a   Nandrot, Emeline F ^a  

^a INSTITUT DE LA VISION   (France)

Author keywords

Cancer; MerTK; Mutations; Phagocytosis; Photoreceptor death; Proto oncogene; RCS rat; Retinal pigment epithelium; Retinitis pigmentosa; Rod cone dystrophies

Indexed keywords

TYROSINE KINASE RECEPTOR; MERTK PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN TYROSINE KINASE;

COLORECTAL CANCER; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE TARGETING; GENETIC VARIABILITY; HUMAN; LEUKEMIA; LYMPHOMA; MERTK GENE; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTO ONCOGENE; RETINA DEGENERATION; ANIMAL; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MUTATION; PHOTORECEPTOR OUTER SEGMENT;

ANIMALS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; PHAGOCYTOSIS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RETINAL DEGENERATION; RETINAL PHOTORECEPTOR CELL OUTER SEGMENT;

EID: 84943338948     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-17121-0_35     Document Type: Chapter

References (48)

1. Bok D, Hall MO (1971) The role of the pigment epithelium in the etiology of inherited retinal dystrophy in the rat. J Cell Biol 49:664-682
2. Brea-Fernández AJ, Pomares E, Brión MJ et al (2008) Novel splice donor site mutation in MERTK gene associated with retinitis pigmentosa. Br J Ophthalmol 92:1419-1423
3. Burstyn-Cohen T, Lew ED, Través PG et al (2012) Genetic dissection of TAM receptor-ligand interaction in retinal pigment epithelial cell phagocytosis. Neuron 76:1123-1132
4. Charbel Issa P, Bolz HJ, Ebermann I et al (2009) Characterisation of severe rod-cone dystrophy in a consanguineous family with a splice site mutation in the MERTK gene. Br J Ophthalmol 93:920-925
5. Conlon TJ, Deng W-T, Erger K et al (2013) Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa. Hum Gene Ther Clin Dev 24:23-28
6. Coppieters F, Van Schil K, Bauwens M et al (2014) Identity-by-descent-guided mutation analysis and exome sequencing in consanguineous families reveals unusual clinical and molecular findings in retinal dystrophy. Genet Med. doi:10.1038/gim.2014.24
7. D'Cruz PM, Yasumura D, Weir J et al (2000) Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet 9:645-651
8. Deng W-T, Dinculescu A, Li Q et al (2012) Tyrosine-mutant AAV8 delivery of human MERTK provides long-term retinal preservation in RCS rats. Invest Ophthalmol Vis Sci 53:1895-1904
9. Dowling JE, Sidman RL (1962) Inherited retinal dystrophy in the rat. J Cell Biol 14:73-109
10. Ebermann I, Walger M, Scholl HP et al (2007) Truncating mutation of the DFNB59 gene causes cochlear hearing impairment and central vestibular dysfunction. Hum Mutat 28:571-577
11. Feng W, Yasumura D, Matthes MT et al (2003) Mertk triggers uptake of photoreceptor outer segments during phagocytosis by cultured retinal pigment epithelial cells. J Biol Chem 277:17016-17022
12. Finnemann SC, Bonilha VL, Marmorstein AD et al (1997) Phagocytosis of rod outer segments by retinal pigment epithelial cells requires alpha(v)beta5 integrin for binding but not for internalization. Proc Natl Acad Sci U S A 94:12932-12937
13. Gal A, Li Y, Thompson DA et al (2000) Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat Genet 26:270-271
14. Graham DK, Dawson TL, Mullaney DL et al (1994) Cloning and mRNA expression analysis of a novel human protooncogene, c-mer. Cell Growth Differ 5:647-657
15. Greenman C, Stephens P, Smith R et al (2007) Patterns of somatic mutation in human cancer genomes. Nature 446:153-158
16. Hall MO, Obin MS, Heeb MJ et al (2005) Both protein S and Gas6 stimulate outer segment phagocytosis by cultured rat retinal pigment epithelial cells. Exp Eye Res 81:581-591
17. Hucthagowder V, Meyer R, Mullins C et al (2012) Resequencing analysis of the candidate tyrosine kinase and RAS pathway gene families in multiple myeloma. Cancer Genet 205:474-478
18. Hurtado B, Muñoz X, Recarte-Pelz P et al (2011) Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM receptor tyrosine kinases in human atherosclerotic carotid plaques. Thromb Haemost 105:873-882
19. Ksantini M, Lafont E, Bocquet B et al (2012) Homozygous mutation in MERTK causes severe autosomal recessive retinitis pigmentosa. Eur J Ophthalmol 22:647-653
20. LaVail MM (1976) Rod outer segment disk shedding in rat retina: relationship to cyclic lighting. Science 194:1071-1074
21. Lierman E, Van Miegroet H, Beullens E et al (2009) Identification of protein tyrosine kinases with oncogenic potential using a retroviral insertion mutagenesis screen. Haematologica 94:1440-1444
22. Li L, Xiao X, Li S (2011) Detection of variants in 15 genes in 87 unrelated Chinese patients with Leber congenital amaurosis. PLoS One 6:e19458
23. Ling L, Templeton D, Kung HJ (1996) Identification of the major autophosphorylation sites of Nyk/Mer, an NCAM-related receptor tyrosine kinase. J Biol Chem 271:18355-18362
24. Linger RMA, Keating AK, Earp HS et al (2008) TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res 100:35-83
25. Linger RMA, Cohen RA, Cummings CT et al (2013a) Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer. Oncogene 32:3420-3431
26. Linger RMA, Lee-Sherick AB, DeRyckere D et al (2013b) Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia. Blood 122:1599-1609
27. Mackay DS, Henderson RH, Sergouniotis PI et al (2010) Novel mutations in MERTK associated with childhood onset rod-cone dystrophy. Mol Vis 16:369-377
28. McHenry CL, Liu Y, Feng W et al (2004) MERTK arginine-844-cysteine in a patient with severe rod-cone dystrophy: loss of mutant protein function in transfected cells. Invest Ophthalmol Vis Sci 45:1456-1463
29. Nagata K, Ohashi K, Nakano T et al (1996) Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases. J Biol Chem 271:30022-30027
30. Nandrot E, Dufour EM, Provost AC et al (2000) Homozygous deletion in the coding sequence of the c-mer gene in RCS rats unravels general mechanisms of physiological cell adhesion and apoptosis. Neurobiol Dis 7:586-599
31. Nandrot EF, Kim Y, Brodie SE et al (2004) Loss of synchronized retinal phagocytosis and agerelated blindness in mice lacking alphavbeta5 integrin. J Exp Med 200:1539-1545
32. Nandrot EF, Anand M, Almeida D et al (2007) Essential role for MFG-E8 as ligand for alphavbeta5 integrin in diurnal retinal phagocytosis. Proc Natl Acad Sci U S A 104:12005-12010
33. Nandrot EF, Silva KE, Scelfo C et al (2012) RPE cells use a MerTK-dependent mechanism to limit alphavbeta5 integrin binding activity. Biol Cell 104:326-341
34. Ostergaard E, Duno M, Batbayli M et al (2011) A novel MERTK deletion is a common founder mutation in the Faroe Islands and is responsible for a high proportion of retinitis pigmentosa cases. Mol Vis 17:1485-1492
35. Schlegel J, Sambade MJ, Sather S et al (2013) MERTK receptor tyrosine kinase is a therapeutic target in melanoma. J Clin Invest 123:2257-2267
36. Scott RS, McMahon EJ, Pop SM et al (2001) Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411:207-211
37. Shahzadi A, Riazuddin SA, Ali S et al (2010) Nonsense mutation in MERTK causes autosomal recessive retinitis pigmentosa in a consanguineous Pakistani family. Br J Ophthalmol 94:1094-1099
38. Siemiatkowska AM, Arimadyo K, Moruz LM et al (2011) Molecular genetic analysis of retinitis pigmentosa in Indonesia using genome-wide homozygosity mapping. Mol Vis 17:3013-3024
39. Smith AJ, Schlichtenbrede FC, Tschernutter M et al (2003) AAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa. Mol Ther 8:188-195
40. Tada A, Wada Y, Sato H et al (2006) Screening of the MERTK gene for mutations in Japanese patients with autosomal recessive retinitis pigmentosa. Mol Vis 12:441-444
41. Tschernutter M, Schlichtenbrede FC, Howe S et al (2005) Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy. Gene Ther 12:694-701
42. Tschernutter M, Jenkins SA, Waseem NH et al (2006) Clinical characterisation of a family with retinal dystrophy caused by mutation in the Mertk gene. Br J Ophthalmol 90:718-723
43. Tworkoski KA, Platt JT, Bacchiocchi A et al (2013) MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL. Pigment Cell Melanoma Res 26:527-541
44. Vollrath D, Feng W, Duncan JL et al (2001) Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk. Proc Natl Acad Sci U S A 98:12584-12589
45. Watanabe T, Kobunai T, Yamamoto Y et al (2011) Differential gene expression signatures between colorectal cancers with and without KRAS mutations: crosstalk between the KRAS pathway and other signalling pathways. Eur J Cancer 47:1946-1954
46. Weier HU, Fung J, Lersch RA (1999) Assignment of protooncogene MERTK (a.k.a. c-mer) to human chromosome 2q14.1 by in situ hybridization. Cytogenet Cell Genet 84:91-92
47. Weinger JG, Omari KM, Marsden K et al (2009) Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions. Am J Pathol 175:283-293
48. Young RW, Bok D (1969) Participation of the retinal pigment epithelium in the rod outer segment renewal process. J Cell Biol 42:392-403